Drug interaction evaluation of the novel phosphodiesterase type 5 inhibitor tunodafil (youkenafil): Effects of tunodafil on omeprazole pharmacokinetics based on CYP2C19 gene polymorphism, and effects of ritonavir on tunodafil pharmacokinetics

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 90142a77bcfd96b4-LAX IP: 116.62.10.13 UTC time: 2025-01-13T08:55:11+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

View original article

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Like

分享书签

0 0 0 0 0 0 0

More from this channel

Drug interaction evaluation of the novel phosphodiesterase type 5 inhibitor tunodafil (youkenafil): Effects of tunodafil on omeprazole pharmacokinetics based on CYP2C19 gene polymorphism, and effects of ritonavir on tunodafil pharmacokinetics

留言 (0)